Challenging Israel
Israeli biotech could soon be playing a much greater role in finding health solutions for the world’s poorest peoples. Read more
Israeli biotech could soon be playing a much greater role in finding health solutions for the world’s poorest peoples. Read more
Man can also be a dog’s best friend. Read more
The next big business opportunity for biotech researchers may be quite close to the classroom. The Massive Open Online Courses (MOOC) revolution is here and it is bringing with it many new possibilities. Read more
While President Obama is reported to be weighing a new American program for mapping the brain and neuro research, Israel’s President Shimon Peres is also doing his part to encourage neuro research. Peres played an active part in setting up a $1 million R&D award for a breakthrough in brain technology. This is open to applicants from around the world. Read more
Israeli biotech comes full circle with the recent Rosetta Green success story. Rosetta Green, a company that specializes in identifying unique genes and developing improved plant traits for the agriculture and biofuel industries, has been purchased by Monsanto for $35 million. Read more
Biotech entrepreneurs looking for new ways to start a company on the global stage may find the example of Alma Bio Therapeutics inspiring and instructive. Read more
Lithuania could become a new hotbed of biotech activity, with job opportunities and fresh domains for outsourcing and clinical trials, if the country is able to maintain the momentum it set into motion during the first Life Sciences Baltics Conference held in Vilnius in mid-September. Read more
The success story of Yosef Behrend suggests an unconventional, though seemingly straightforward way to create a biotechnology business. Read more
Now that the Israel monoclonal antibody forum exists, the reasons for founding it seem as obvious as do the reasons why it has become a success. The forum was the initiative of Tehila Ben-Moshe, CEO of cCam Biotherapeutics, who thought that companies with MAb-based technologies like hers, especially start-ups, could benefit from one another by pooling information. She didn’t know how many MAb companies were within driving distance, as there is no official breakdown of the local biotech industry according to technological platforms. Read more
Aspiring biotech entrepreneurs often try to find a novel technology of their own that will lead to commercial success. But, as the career of Itschak Lamensdorf suggests, sometimes the best way to be both innovative and successful can come from facilitating the projects of others. When Lamensdorf completed his post-doc studies at the NIH in 2000, like many other young grads, he plunged into the business world with the ambition of using basic research that he had worked on as the foundation for a commercial start-up venture. The company he initiated was based on a modified antisense platform technology for … Read more
Recent comments on this blog
New Trump Travel Ban a Detriment to Biotech
More on the Shelf
My Biotech Heroes